Home
Subscription
January 2025 issue
BACK ISSUES
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
|
2013 Issues
December 2013 Issue
• New Drug Review: Dabrafenib mesylate (Tafinlar)
• New Drug Review: Trametinib dimethyl sulfoxide (Mekinist)
• Index for 2013
November 2013 Issue
• Feature - Inspiration!
• New Drug Review: Crofelemer (Fulyzaq)
October 2013 Issue
• Feature - Obtaining Health Insurance that Isn't Understood Using a System that Isn't Working - And the Situation Will Get Worse if there is not Compromise!
• New Drug Review: Ospemifene (Osphena)
September 2013 Issue
• Feature - Boards of Pharmacy Should Discontinue Issuing Licenses to Pharmacies that Sell Tobacco Products and to Pharmacies that are in Facilities that Sell Tobacco Products
• New Drug Review: Vilanterol trifenatate/fluticasone furoate (Breo Ellipta)
August 2013 Issue
• Feature - Mail-order Pharmacy Threatens the Role of Pharmacists as Health Professionals
• New Drug Review: Dimethyl fumarate (Tecfidera)
July 2013 Issue
• Feature - Pharmacists Be On Guard! For the Protection of Your Patients and Yourselves
• New Drug Review: Lorcaserin (Belviq)
June 2013 Issue
• Feature - Walgreens Challenges CVS in the Race to the Bottom - But No Individuals are Accountable!
• New Drug Review: Alogliptin benzoate (Nesina)
May 2013 Issue
• Feature - Pfizer's Viagra Promotion Puts Patients at Risk and is an Insult to Local Pharmacists
• New Drug Review: Canagliflozin (Invokana)
April 2013 Issue
• Feature - Pharmacy as a Career Choice? YES!
• New Drug Review: Apixaban (Eliquis)
March 2013 Issue
• Feature - "I Quit CVS Today"
• New Drug Review: Linaclotide (Linzess)
February 2013 Issue
• Feature - Express Scripts Almost Discovers Conscience - But Fails to Do So!
• New Drug Review: Teriflunomide (Aubagio)
January 2013 Issue
• Feature - The APhA and ASHP Should Merge!
• New Drug Review: Aclidinium bromide (Tudorza Pressair)
• New Therapeutic Agents Marketed in the United States in 2012 (Table)
| |
